ArticleBreast cancer research : BCR2016

Antitumor activity of Cetuximab in combination with Ixabepilone on triple negative breast cancer stem cells.

Tomonori Tanei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.